Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by fredgoodwinsonon May 29, 2020 11:00am

89 Views

Post# 31087602

RE:RE:Is MDNA holding TLT back?

This is good and welcome news for GBM as there are few treatment options but it`s no panacea.
The idea that it would deleteriously affect TLT`s own prospects in this indication is fanciful.

Seems that even our own shareholders are in for a big surprise when we finally get into the Clinic with Rutherrin.

Bullboard Posts

Sirios Resource discovers visible gold in Quebec